VERSACLOZ is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Jazz Pharmaceuticals, Inc.. The primary component is Clozapine.
| Product ID | 18860-121_f7d4b279-d9de-4fb3-b67c-24e2b4d39b50 |
| NDC | 18860-121 |
| Product Type | Human Prescription Drug |
| Proprietary Name | VERSACLOZ |
| Generic Name | Clozapine |
| Dosage Form | Suspension |
| Route of Administration | ORAL |
| Marketing Start Date | 2013-02-15 |
| Marketing End Date | 2019-05-31 |
| Marketing Category | NDA / NDA |
| Application Number | NDA203479 |
| Labeler Name | Jazz Pharmaceuticals, Inc. |
| Substance Name | CLOZAPINE |
| Active Ingredient Strength | 50 mg/mL |
| Pharm Classes | Atypical Antipsychotic [EPC] |
| NDC Exclude Flag | N |
| Marketing Start Date | 2013-02-15 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA203479 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2013-02-15 |
| Marketing End Date | 2019-05-31 |
| Ingredient | Strength |
|---|---|
| CLOZAPINE | 50 mg/mL |
| SPL SET ID: | 693cb9d4-39db-4ecf-9eae-b01f06f8d5d1 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 18860-121 | VERSACLOZ | VERSACLOZ |
| 52817-601 | VERSACLOZ | VERSACLOZ |
| 0093-3010 | Clozapine | clozapine |
| 0093-3011 | Clozapine | clozapine |
| 0093-3012 | Clozapine | clozapine |
| 0093-3086 | Clozapine | clozapine |
| 0093-3087 | Clozapine | clozapine |
| 0093-4359 | Clozapine | Clozapine |
| 0093-4404 | Clozapine | Clozapine |
| 0093-4405 | Clozapine | Clozapine |
| 0093-5376 | Clozapine | Clozapine |
| 0093-5377 | Clozapine | Clozapine |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() VERSACLOZ 85481766 4538214 Live/Registered |
TASMAN PHARMA, INC. 2011-11-28 |